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Abstract—The reactions of 1,4-bis[2-(tributylstannyl)tetrazol-5-yl]benzene with a,u-dibromoalkanes were carried out in order to synthesise
pendant alkyl halide derivatives of the parent bis-tetrazole. This led to the formation of several alkyl halide derivatives, substituted variously at
N1 or N2 on the tetrazole ring. The crystal structures of 1,4-bis[(2-(4-bromobutyl)tetrazol-5-yl)]benzene (2-N,2-N0), 1,4-bis[(2-(4-bromo-
butyl)tetrazol-5-yl)]benzene (1-N,2-N0) and 1,4-bis[(2-(8-bromooctyl)tetrazol-5-yl)]benzene (2-N,2-N0) are reported. Further discussion
involves the structure of 1,4-bis[2-(6-bromohexyl)-2H-tetrazol-5-yl]benzene (2-N,2-N0) previously reported.
 2006 Elsevier Ltd. All rights reserved.1. Introduction
The synthesis of tetrazoles from a cycloaddition reaction
between a nitrile and an azide is well documented1–6 since
tetrazoles have roles in coordination chemistry as ligands,
in medicinal chemistry as metabolically stable surrogates
for carboxylic acids and in materials science applications,
including photography and explosives. The interest in the
ability of tetrazoles to mimic the carboxylic acid group has
motivated the incorporation of tetrazoles into biologically
active molecules.2 This potential use has led to the in-
corporation in therapeutic applications, including their
incorporation in pharmacologically active compounds with
anti-hypertensive, anti-allergic and antibiotic activities.3
In recent years, particular attention has been directed to-
wards the use of polydentate aromatic nitrogen heterocycles,
specifically ligands with five-membered rings (azoles).
Among these, imidazoles and triazoles have been exten-
sively used for their ability to construct open framework net-
works with a wide variety of topologies. Tetrazoles exhibit
a strong networking ability usually acting as mono- or biden-
tate ligands in most of the reported complexes.7–9 A possible
application for these materials as molecular hosts is in
generating supramolecular arrays, which embody additional
functional groups capable of metal complexation. This
would result in a metallotetrazole framework with potential
as new catalysts, anti-bacterial or therapeutic agents. Our
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doi:10.1016/j.tet.2006.07.093interest in macrocycles containing tetrazoles surrounds their
use as precursors for the formation of new functionalised
poly-tetrazoles as, for example, sensors or in molecular
recognition.
Molloy et al.,5 Butler and Fleming10 have synthesised bis-
(bromoalkyltetrazolyl)benzenes from either tributylstannyl-
substituted bis-tetrazoles or N-unsubstituted tetrazoles with
dihaloalkanes with the 2-N,2-N0-isomer again being the pre-
dominant product; Molloy et al. studied both the 1,2- and
1,3-substituted bis-tetrazole while Butler and Fleming
looked only at the 1,3-unsubstituted bis-tetrazoles. In fact,
Butler has succeeded in using these bis-(bromoalkyltetra-
zolyl)-benzenes to generate the tetra-tetrazolemacrocycle
(Fig. 1), which include a cavity of variable dimensions
tailored by both the length and flexibility of the alkyl chain
and also the substitution position on the benzene ring.10–12
Furthermore, the X-ray crystal structure of one such macro-
cycle has been reported.13
We have previously reported our initial findings regarding
the addition of pendant short-chain alkyl halide arms of
some bis-tetrazoles, which yielded not only bis-tetrazole
N
N
N
N
N
N
N
N
X
N
N
N
N
N
N
N
N
X
Y
Y
Figure 1. Schematic of tetratetrazole macrocycle with X¼substituted
benzene and Y¼alkyl chain.
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rather surprisingly, bis-tetrazole derivatives with pendant
vinyl arms.14 The X-ray crystal structure of 1,4-bis(tetrazole)-
benzene with bromohexyl pendant arms has been reported,
but with limited structural and spectroscopic discussion.15
In this paper, we report the reactions of 1,4-bis(tetrazole)-
benzenes with various long chain a,u-dibromoalkanes and
discuss their spectroscopic results. The crystal structures
of three derivatives are also presented herein.
2. Results and discussion
While alkylation of 5-substituted mono-tetrazole derivatives
is known to lead to mixtures of 1-N- and 2-N-substituted
products,1 the regioselectivity being dependent on the reac-
tion conditions and the nature of the C- and N-substituents,
the alkylation of bis-tetrazole derivatives can lead to several
diverse products. For example, the reaction of 1,2-bis[2-(tri-
butylstannyl)tetrazol-5-yl]benzene (1,2-(Bu3SnN4C)2C6H4)
with 1,2-dibromoethane, reported by Molloy et al.,5 has
been shown to form either a cyclophane or bis(bromoethyl-
tetrazolyl)benzenes, depending on the ratio of the dibromo-
ethane employed in the reaction. When using a 10-fold
excess, the cyclophane was obtained; a larger excess (25:1)
resulted in the formation of the bis(bromoethyltetrazolyl)-
benzenes, either the 2-N,2-N0- or the 1-N,2-N0-isomer, with
the 2-N,2-N0-isomer predominating in a ratio of ca. 3:1. We
have recently reported the reactions of either 1,n-bis(tetra-
zol-5-yl)benzene (1,n-(HN4C)2C6H4) or 1,n-bis[2-(tributyl-
stannyl)tetrazol-5-yl]benzene (1,n-(Bu3SnN4C)2C6H4)
(n¼2, 3, 4) with 1,2-dibromoethane, which yielded com-
pounds containing pendant bromoethyl or vinyl groups
with substitution occurring at either 1-N,2-N0 or 2-N,2-N0,
respectively.14
Our strategy was to use both of these approaches, that is,
the use of both 1,n-bis(tetrazol-5-yl)benzene and 1,n-bis[2-
(tributylstannyl)tetrazol-5-yl]benzene, to obtain sufficient
quantities of the 2-N,2-N0-isomer of various bis(bromoalkyl-
tetrazolyl)benzenes with a view towards generating deriva-
tised tetra-tetrazole macrocycles. One approach involved
the reactions of the 1,4-bis(tetrazole)benzene with long chain
a,u-dibromoalkanes. When the reactions of 1,4-bis(tetrazol-
5-yl)benzene (1,4-(HN4C)2C6H4) with either 1,4-dibromo-
butane, 1,6-dibromohexane or 1,8-dibromooctane were
heated as neat suspensions, no products were obtained and
starting materials were recovered in all cases. Furthermore,
when the reactions were carried out in the presence of tri-
ethylamine in either methanol or toluene with heating to
reflux for 24 h, we found that the recovered material, after
work-up, contained mainly starting bis-tetrazoles, with
approx. 30% of products. We were able to grow crystals of
1,4-bis[(2-bromohexyl)tetrazol-5-yl]benzene, prepared by
this method, which we have already reported.8 However,
when the reactions of 1,4-bis[2-(tributylstannyl)tetrazol-5-
yl]benzene (1,4-(Bu3SnN4C)2C6H4) with either 1,4-dibromo-
butane, 1,6-dibromohexane or 1,8-dibromooctane were
heated as neat suspensions, two products were obtained in
relatively high yields, in all the reactions, as well as some
recovered starting material (Scheme 1), suggesting that the
organotin route was the better method for the synthesis of
this particular type of material. It should be pointed out thatneither the cyclophane product nor any products containing
additions on one ring only were obtained.
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Scheme 1.
Column chromatography, using hexane/ethyl acetate mix-
tures as eluent, separated the products from the reactants.
1H and 13C NMR spectra were obtained for all samples
and revealed that both the 2-N,2-N0- and the 1-N,2-N0-iso-
mers of the bis(bromoalkyltetrazolyl)benzene had formed
in the reaction, but the expected cyclophane was not present.
The isomeric 2-N,2-N0- and 1-N,2-N0-derivatives are readily
distinguishable by their 1H and 13C NMR spectra,5,10,14 with
the 13C NMR chemical shift of the tetrazole carbon atom
appearing at ca. 154.0 and 164.0 ppm in 1,5- and 2,5-disub-
stituted tetrazoles, respectively. The symmetrical 2-N,2-N0-
substituted compounds thus gave rise to a single resonance
at 164.0 ppm while both signals were apparent in the 1-N,
2-N0-substituted compounds. For example, 1,4-bis[(2-bro-
mobutyl)tetrazol-5-yl]benzene (2-N,2-N0) (2a) has a single
peak at 164.6 ppm while 1,4-bis[(2-bromobutyl)tetrazol-5-
yl]benzene (1-N,2-N0) (2b) has two peaks at 153.8 and
164.0 ppm. The main difference in the 1H NMR spectra of
the isomers was the doubling of signals in the case of the
1-N,2-N0-derivatives.
Crystals of compounds 2a, 2b and 4a, suitable for an X-ray
diffraction study, were obtained from chloroform and the
structures confirmed the presence of the pendant bromoalkyl
groups at the 2-N,2-N0-positions for 2a and 4a and at the
1-N,2-N0-positions for 2b (Figs. 2, 3 and 4). Table 1 shows
important bond lengths and angles for the three structures.
We have previously published the structure of 3a,15 allowing
us to include this also in our comparison of the 2-N,2-N0
compounds.
The structures of 2a, 3a and 4a exhibit regularity. In each
case, the molecular unit is centrosymmetric in the solid state
and is sited on a crystallographic inversion centre. The tetra-
zole rings are essentially coplanar with the benzene ring to
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fully extended conformations, projecting to either side of
this plane. The long axes of the alkyl chains form angles
of ca. 145 to the molecular plane (measured by the N4–
C5–C7 angle in 2a, and equivalent angles in 3a and 4a). Ad-
jacent molecules adopt slipped p-stacking arrangements,
with distances of ca. 3.4 A˚ between the least squares planes
of the molecules, and centroid–centroid separations of ca.
4.6 A˚ (the lattice parameter a). The stacks are arranged
into 2-D layers so that molecules in adjacent stacks are close
to co-planar, introducing relatively short contacts in the
range 2.7–2.8 A˚ between one H atom of the first methylene
group in the bromoalkyl chain and the 1-N atom of the
neighbouring tetrazole rings. The alignment of neighbouring
stacks into a 2-D arrangement is consistent with effective
lateral packing of the alkyl chains: in each case, the H atoms
of the methylene groups in one chain project into the gaps
Figure 2. Molecular structure of 2a, showing the labelling scheme for the
crystallographically independent atoms. The non-labelled half of the mole-
cule is related to the labelled half by a centre of inversion. Ellipsoids are
represented at 50% probability for non-H atoms.
Figure 3. Molecular structure of 2b, showing the labelling scheme used.
Ellipsoids are represented at 50% probability for non-H atoms.
Figure 4. Molecular structure of 4a, showing the labelling scheme for the
crystallographically independent atoms. The non-labelled half of the mole-
cule is related to the labelled half by a centre of inversion. Ellipsoids are
represented at 50% probability for non-H atoms.between methylene groups in the neighbouring chains. The
2-D layer arrangements are effectively identical in each of
2a, 3a and 4a. Adjacent 2-D layers meet so as to bring the
terminal CH2–Br bonds into an offset co-linear alignment,
forming ‘Type I’ Br/Br interactions, as classified previ-
ously by Pedireddi et al.16 The intermolecular Br/Br
distances lie in the range 3.4802(4)–3.5351(8) A˚, consider-
ably shorter than twice the bromine van der Waals radius
(3.90 A˚) and within the range of those values previously
reported, 3.415–3.691 A˚.17–20
In the crystal structure of 2b, the two tetrazole rings in each
molecule are essentially co-planar (rms deviation of 10 fitted
atoms¼0.007 A˚), but the plane of the central benzene ring
forms a dihedral angle of 9.7(3) with this plane. The bromo-
butyl chains form greater angles to the molecular plane (N4–
C9–C11 and N6–C13–C15 both ca. 95.5), and the terminal
CH2–Br bond vectors lie perpendicularly close to each other
(Fig. 3). The arrangement of the central portions of the mole-
cules in the crystal structure is closely comparable to that
in 2a, 3a and 4a. The least-squares planes of the p-stacked
molecules are separated by ca. 3.5 A˚, with centroid–centroid
separations of ca. 4.4 A˚. Adjacent molecules in the stacks
are related by centres of inversion. The molecules in adja-
cent stacks are again close to co-planar, but with a slightly
greater lateral offset along the long axes of the molecules
in 2b compared to 2a. The introduction of a short H/H con-
tact (ca. 2.29 A˚) between adjacent benzene rings, and the
twisting of these rings from the planes of the tetrazole rings
may be attributed at least in part to alleviation of the steric
constraints associated with this close contact. The terminal
CH2–Br bonds again form ‘Type I’ Br/Br interactions,
with intermolecular Br/Br distances of 3.591(2) and
3.677(2) A˚. It is noteworthy that while one of these Br/
Br distances is closely comparable to those in 2a, 3a and
4a, the second is significantly longer. This less-than-optimal
intermolecular contact presumably contributes to the signif-
icantly lower melting point of 2b (ca. 110 C) compared to
the isomeric 2a (ca. 140 C).
3. Conclusions
The reactions of 1,4-(Bu3SnN4C)2C6H4 with 1,4-dibromo-
butane, 1,6-dibromohexane and 1,8-dibromooctane yield
compounds containing pendant bromoalkyl groups with
Table 1. Selected bond lengths (A˚) and angles () for 2a, 3a and 4a
2a 3a 4a
Bond lengths
C(1)–C(2) 1.389(4) 1.389(4) 1.378(3)
C(2)–C(3) 1.399(4) 1.402(3) 1.395(3)
C(3)–C(4) 1.477(4) 1.463(3) 1.469(3)
C(4)–N(1) 1.352(4) 1.356(3) 1.360(3)
C(4)–N(2) 1.334(4) 1.340(3) 1.323(3)
N(1)–N(3) 1.324(4) 1.321(3) 1.324(3)
N(3)–N(4) 1.325(4) 1.333(3) 1.319(3)
N(4)–N(2) 1.330(3) 1.328(3) 1.329(3)
N(4)–C(5) 1.472(4) 1.463(3) 1.458(3)
Bond angles
C(4)–N(1)–N(3) 106.1(3) 106.2(2) 105.7(2)
N(1)–N(3)–N(4) 105.9(2) 106.2(2) 106.35(19)
N(3)–N(4)–N(2) 114.2(2) 113.8(2) 113.7(2)
N(4)–N(2)–C(4) 101.4(3) 102.2(2) 102.1(2)
N(2)–C(4)–N(1) 112.4(3) 112.2(2) 112.2(2)
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crystal structures of three derivatives were obtained, includ-
ing both the 1-N,2-N0 and 2-N,2-N0-isomers of one deriva-
tive. No cyclophane products were observed from any of
the reactions. Similar reactions involving 1,3-dibromopro-
pane, 1,5-dibromopentane and 1,7-dibromoheptane are cur-
rently being investigated, as are macrocyclic ring closure
reactions with 1,4-(Bu3SnN4C)2C6H4 and metal complexa-
tion reactions with the resulting macrocyclic ring.
4. Experimental
4.1. General
1H and 13C NMR (d ppm; J Hz) spectra were recorded on
a JOEL JNM-LA300 FT-NMR spectrometer using saturated
CDCl3 solutions with Me4Si reference, unless indicated
otherwise, with resolutions of 0.18 Hz and 0.01 ppm. Infra-
red spectra (cm1) were recorded as KBr discs or liquid films
between KBr plates using a Nicolet Impact 410 FT-IR. Melt-
ing points were measured with a Stuart Scientific melting
point apparatus (SMP1) without correction. Microanalysis
was carried out at the Microanalytical Laboratory of Univer-
sity College, Dublin. Standard Schlenk techniques were
used throughout.
4.2. Syntheses
1,4-(Bu3SnN4C)2C6H4 (1) was prepared as described previ-
ously.14 All other reagents were commercially obtained and
used without further purification. Caution: owing to their po-
tentially explosive nature, all preparations of and subsequent
reactions with organotin azides and tetrazoles were con-
ducted under an inert atmosphere behind a rigid safety
screen.
The numbering scheme for the 1,4-bis-tetrazoles is shown
in Figure 5 and all NMR assignments are based on these
diagrams.
4.3. General synthesis of compounds
1,4-(Bu3SnN4C)2C6H4 (1) (10 g, 126.2 mmol) and the ap-
propriate a,u-dibromoalkane (300 mmol) were heated to
120 C for 24 h, under nitrogen. After cooling, the excess
a,u-dibromoalkane was removed under reduced pressure
to afford the mixture of isomers a and b, as well as some
starting bis-tetrazole. These were seperated by column chro-
matography on silica gel (initially at the ratio of hexane/
ethyl acetate 80:20, followed by the ratio 60:40). All
compounds were recrystallised from chloroform.
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Figure 5. Labelling scheme used for central core in the 1,4-bis(tetrazole)
derivatives.4.3.1. 1,4-Bis[2-(4-bromobutyl)tetrazol-5-yl]benzene (2-
N,2-N0) (2a). White solid. Anal. Calcd for C16H20Br2N8:
C, 39.69; H, 4.16; N, 23.14. Found: C, 39.61; H, 4.15; N,
22.85; Yield: 64%, 3.91 g, 8.1 mmol; nmax (KBr) 2958,
1609, 1584, 1538, 1503, 1443, 1384, 1357, 1254, 1222,
1190, 1035, 1006, 875, 782, 753 cm1; mp 138–142 C;
dH: 1.95 [m, 4H, CH2], 2.75 [m, 4H, CH2], 3.47 [t, 4H,
J¼6.6 Hz, CH2Br], 4.74 [t, 4H, J¼6.6 Hz, NCH2], 8.28 [s,
4H, H1–C6H4]; dC: 27.8 [CH2], 29.2 [CH2], 32.2 [CH2],
52.3 [CH2N], 127.3 [C
1–C6H4], 129.1 [i–C6H4], 164.6
[CN4].
4.3.2. 1,4-Bis[2-(4-bromobutyl)tetrazol-5-yl]benzene (1-
N,2-N0) (2b). White solid. Anal. Calcd for C16H20Br2N8: C,
39.69; H, 4.16; N, 23.14. Found: C, 39.92; H, 4.13; N,
23.04; Yield: 21%, 1.28 g, 2.6 mmol; mp 108–112 C; nmax
(KBr) 2929, 2853, 1628, 1558, 1538, 1469, 1438, 1370,
1307, 1260, 1225, 1195, 1112, 1037, 1005, 847, 734,
645 cm1; dH: 1.95 [m, 4H, CH2], 2.15 [m, 2H, CH2], 2.28
[m, 2H, CH2], 3.40 [t, 2H, J¼6.6 Hz, CH2Br], 3.47 [t, 2H, J¼
6.6 Hz, CH2Br], 4.52 [t, 2H, J¼6.6 Hz, N1CH2], 4.75 [t, 2H,
J¼6.6 Hz, N2CH2], 7.85 [d, 2H, J¼6.6 Hz, H2–C6H4], 8.38
[d, 2H, J¼6.6 Hz, H1–C6H4]; dC: 27.8 [CH2], 28.2 [CH2],
29.1 [CH2], 29.2 [CH2], 32.0 [CH2], 32.1 [CH2], 47.3
[CH2N], 52.4 [CH2N], 125.5 [i–C6H4], 127.7 [C
1–C6H4],
129.3 [C2–C6H4], 130.3 [i
0–C6H4], 153.8 [CN4], 164.0 [CN4].
4.3.3. 1,6-Bis[2-(6-bromohexyl)tetrazol-5-yl]benzene (2-
N,2-N0) (3a). White solid. Anal. Calcd for C20H28Br2N8:
C, 44.46; H, 5.22; N, 20.74. Found: C, 44.45; H, 5.20; N,
20.35; Yield: 65%, 4.43 g, 8.2 mmol; mp 104–106 C;
nmax (KBr) 2931, 2862, 1610, 1580, 1543, 1515, 1449,
1396, 1352, 1293, 1250, 1182, 1150, 1082, 1041, 897,
783, 756 cm1; dH: 1.40 [m, 4H, CH2], 1.55 [m, 4H, CH2],
1.88 [m, 4H, CH2], 2.11 [m, 4H, CH2], 3.41 [t, 4H,
J¼6.6 Hz, CH2Br], 4.69 [t, 4H, J¼6.6 Hz, NCH2], 8.28 [s,
4H, H1–C6H4]; dC: 25.6 [CH2], 27.5 [CH2], 29.2 [CH2],
32.4 [CH2], 33.5 [CH2], 53.1 [CH2N], 127.3 [C
1–C6H4],
129.1 [i–C6H4], 164.5 [CN4].
4.3.4. 1,6-Bis[2-(6-bromohexyl)tetrazol-5-yl]benzene (1-
N,2-N0) (3b). White solid. Anal. Calcd for C20H28Br2N8:
C, 44.46; H, 5.22; N, 20.74. Found: C, 44.40; H, 5.20; N,
20.45; Yield: 12%, 0.82 g, 1.5 mmol; mp 84–86 C; nmax
(KBr) 2930, 2865, 1625, 1550, 1538, 1470, 1436, 1379,
1316, 1262, 1224, 1195, 1110, 1036, 1015, 846, 734,
649 cm1; dH: 1.46 [m, 4H, CH2], 1.84 [m, 4H, CH2], 2.05
[m, 8H, CH2], 3.36 [t, 2H, J¼6.6 Hz, CH2Br], 3.41 [t, 2H, J¼
6.6 Hz, CH2Br], 4.51 [t, 2H, J¼6.6 Hz, N1CH2], 4.70 [t, 2H,
J¼6.6 Hz, N2CH2], 7.84 [d, 2H, J¼6.6 Hz, H2–C6H4], 8.32
[d, 2H, J¼6.6 Hz, H1–C6H4]; dC: 25.3 [CH2], 25.4 [CH2],
27.1 [CH2], 27.2 [CH2], 28.9 [CH2], 29.3 [CH2], 32.1
[CH2], 32.2 [CH2], 33.3 [CH2], 33.4 [CH2], 47.9 [CH2N],
53.0 [CH2N], 125.5 [i–C6H4], 127.7 [C
1–C6H4], 129.3 [C
2–
C6H4], 130.3 [i
0–C6H4], 153.8 [CN4], 164.1 [CN4].
4.3.5. 1,8-Bis[2-(8-bromooctyl)tetrazol-5-yl]benzene (2-
N,2-N0) (4a). White solid. Anal. Calcd for C24H36Br2N8: C,
48.33; H, 6.08; N, 18.79. Found: C, 47.95; H, 6.08; N,
18.48; Yield: 68%, 5.12 g, 8.6 mmol; mp 88–94 C; nmax
(KBr) 2929, 2852, 1629, 1557, 1468, 1430, 1354, 1357,
1266, 1226, 1198, 1048, 1006, 854, 744, 723, 647 cm1; dH:
1.39 [m, 16H, CH2], 1.85 [m, 4H, CH2], 2.08 [m, 4H, CH2],
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8.28 [s, 4H, H1–C6H4]; dC: 26.3 [CH2], 27.9 [CH2], 28.5
[CH2], 28.7 [CH2], 29.3 [CH2], 32.7 [CH2], 33.9 [CH2],
53.3 [CH2N], 127.3 [C
1–C6H4], 129.1 [i–C6H4], 164.5 [CN4].
4.3.6. 1,8-Bis[2-(8-bromooctyl)tetrazol-5-yl]benzene (1-
N,2-N0) (4b). White solid. Anal. Calcd for C24H36Br2N8: C,
48.33; H, 6.08; N, 18.79. Found: C, 48.16; H, 6.07; N,
18.58; Yield: 10%, 0.75 g, 1.3 mmol; mp 64–68 C; nmax
(KBr) 2929, 2853, 1626, 1550, 1538, 1469, 1434, 1378,
1303, 1271, 1226, 1197, 1112, 1044, 1003, 848, 736,
645 cm1; dH: 1.29 [m, 8H, CH2], 1.37 [m, 8H, CH2], 1.82
[m, 4H, CH2], 1.95 [m, 2H, CH2], 2.09 [m, 2H, CH2], 3.38
[t, 2H, J¼6.6 Hz, CH2Br], 3.40 [t, 2H, J¼6.6 Hz, CH2Br],
4.46 [t, 2H, J¼6.6 Hz, N1CH2], 4.69 [t, 2H, J¼6.6 Hz,
N2CH2], 7.82 [d, 2H, J¼6.6 Hz, H2–C6H4], 8.36 [d, 2H, J¼
6.6 Hz, H1–C6H4]; dC: 26.2 [CH2], 26.3 [CH2], 27.9 [CH2],
28.0 [CH2], 28.4 [CH2], 28.5 [CH2], 28.7 [CH2], 29.3 [CH2],
29.7 [CH2], 32.6 [CH2], 32.7 [CH2], 33.8 [CH2], 48.2
[CH2N], 53.4 [CH2N], 125.7 [i–C6H4], 127.6 [C
1–C6H4],
129.3 [C2–C6H4], 130.3 [i
0–C6H4], 153.8 [CN4], 163.8 [CN4].
4.4. X-ray crystallography
Suitable crystals of 2a, 2b and 4a for X-ray study were ob-
tained by recrystallisation from chloroform solutions. Data
were collected at 180(2) K on a Bruker Nonius X8 APEX
II diffractometer,21 and a multi-scan correction was ap-
plied.22 The structures were refined against F2 using all
data.23 Hydrogen atoms were placed at calculated positions
and refined using a riding model.
4.4.1. Compound 2a. Crystal data: C16H20Br2N8,
M¼484.22, triclinic, a¼4.5722(7), b¼5.8805(9), c¼
18.119(3) A˚, a¼96.943(6), b¼96.426(6), g¼101.287(6),
U¼469.61(13) A˚3, space group P1, Z¼1, m(MoKa)¼
4.334 mm1. 7346 data (1717 unique, Rint¼0.0386) were
measured in the range 3.59<q<25.74. R1(I>2s(I))¼
0.0321 and wR2(all data)¼0.0815. Goodness of fit on
F2¼1.06. CCDC No. 604247.
4.4.2. Compound 2b. Crystal data: C16H20Br2N8,
M¼484.22, triclinic, a¼6.7256(14), b¼8.1427(19), c¼
17.186(4) A˚, a¼96.972(8), b¼92.193(8), g¼90.034(8),
U¼933.5(4) A˚3, space group P1, Z¼2, m(MoKa)¼
4.361 mm1. 11127 data (3428 unique, Rint¼0.0607) were
measured in the range 3.59<q<25.84. R1(I>2s(I))¼
0.0906 and wR2(all data)¼0.2519. Goodness of fit on
F2¼1.04. CCDC No. 604248.
4.4.3. Compound 4a. Crystal data: C24H36Br2N8,
M¼596.43, triclinic, a¼4.6665(5), b¼5.6593(5), c¼
25.284(2) A˚, a¼92.812(3), b¼90.773(4), g¼102.138(3),
U¼651.82(10) A˚3, space group P1, Z¼1, m(MoKa)¼
3.138 mm1. 11318 data (2448 unique, Rint¼0.0477) were
measured in the range 3.69<q<25.84.R1(I>2s(I))¼0.0338
and wR2(all data)¼0.0863. Goodness of fit on F2¼1.04.
CCDC No. 604249.
4.5. Crystallographic data
Crystallographic data for 2a, 2b and 4a have been deposited
with the Cambridge Crystallographic Data Centre. Copies ofthis information may be obtained free of charge from
deposit@ccdc.cam.ac.uk or www: http://www.ccdc.cam.ac.uk.
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